MIM Software receives FDA clearance to market products running on tablets through thin client technology

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

MIM Software announced this week it has received 510(k) clearance from the FDA. The company can now market its full product line running on tablets through thin client technology.

Jerimy Brockway, MIM vice president of engineering, said in a prepared statement that this makes using the company’s products much more convenient.

“Receiving 510(k) clearance gives MIM users the ability to access all of the technology and power of our leading products on a mobile device,” Jerimy Brockway, MIM vice president of engineering, said in a prepared statement. “This allows physicians to work on a patient case on the same software after they leave the office.”

MIM also announced that it will be demonstrating its product line from booth # 931 at the Society of Nuclear Medicine and Molecular Imaging 2016 Annual Meeting in San Diego, Calif., June 11-15.